Granahan Investment Management’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-342,586
Closed -$5.92M 170
2025
Q3
$5.92M Sell
342,586
-571,036
-63% -$7.03M 0.24% 86
2025
Q2
$8.57M Buy
913,622
+437,676
+92% +$3.59M 0.35% 72
2025
Q1
$3.38M Buy
475,946
+169,436
+55% +$1.71M 0.17% 115
2024
Q4
$3.57M Buy
306,510
+22,976
+8% +$359K 0.15% 127
2024
Q3
$5.83M Buy
283,534
+68,624
+32% +$1.58M 0.23% 115
2024
Q2
$4.81M Sell
214,910
-5,309
-2% -$126K 0.19% 127
2024
Q1
$6.06M Sell
220,219
-37,572
-15% -$1.04M 0.21% 117
2023
Q4
$7.86M Buy
257,791
+52,600
+26% +$1.51M 0.26% 100
2023
Q3
$6.49M Sell
205,191
-56,674
-22% -$2.2M 0.23% 112
2023
Q2
$10.7M Buy
261,865
+2,581
+1% +$105K 0.33% 84
2023
Q1
$9.66M Buy
259,284
+41,661
+19% +$1.63M 0.29% 92
2022
Q4
$7.59M Buy
217,623
+66,788
+44% +$3.18M 0.23% 107
2022
Q3
$8.44M Sell
150,835
-13,510
-8% -$838K 0.28% 100
2022
Q2
$8.51M Buy
164,345
+71,736
+77% +$3.64M 0.29% 90
2022
Q1
$6.73M Sell
92,609
-23,174
-20% -$1.96M 0.17% 120
2021
Q4
$13.7M Sell
115,783
-71,202
-38% -$8.92M 0.28% 98
2021
Q3
$25.1M Sell
186,985
-38,818
-17% -$5.88M 0.48% 48
2021
Q2
$36.6M Buy
225,803
+16,414
+8% +$1.28M 0.68% 36
2021
Q1
$16.8M Buy
209,389
+87,246
+71% +$5.86M 0.36% 64
2020
Q4
$6.64M Buy
122,143
+48,109
+65% +$1.75M 0.15% 112
2020
Q3
$1.47M Sell
74,034
-2,271
-3% -$47.4K 0.05% 164
2020
Q2
$1.6M Buy
76,305
+16,963
+29% +$288K 0.06% 159
2020
Q1
$726K Sell
59,342
-765
-1% -$10.3K 0.04% 168
2019
Q4
$882K Buy
60,107
+416
+0.7% +$5.79K 0.04% 160
2019
Q3
$797K Buy
59,691
+4,528
+8% +$72.2K 0.04% 162
2019
Q2
$903K Sell
55,163
-1,597
-3% -$25.1K 0.04% 165
2019
Q1
$969K Sell
56,760
-4,074
-7% -$60.7K 0.05% 172
2018
Q4
$830K Sell
60,834
-21,525
-26% -$400K 0.06% 170
2018
Q3
$2.36M Sell
82,359
-38,286
-32% -$1.11M 0.13% 143
2018
Q2
$3.3M Buy
120,645
+10,203
+9% +$247K 0.2% 126
2018
Q1
$2.33M Sell
110,442
-20,166
-15% -$496K 0.17% 143
2017
Q4
$2.51M Sell
130,608
-155,536
-54% -$3.59M 0.2% 132
2017
Q3
$7.11M Buy
286,144
+18,784
+7% +$354K 0.59% 61
2017
Q2
$4.28M Buy
+267,360
New +$3.74M 0.39% 91

Other funds holding NTLA